Abstract The Val158Met (rs4680) single-nucleotide polymorphism (SNP) of the catechol-O-methyltransferase gene (COMT) influences executive function and prefrontal function through its effect on dopamine (DA) metabolism. Both HIV and the Val allele of the Val158Met SNP are associated with compromised executive function and inefficient prefrontal function. The present study used behavioral and neuroimaging techniques to determine independent and interactive associations between HIV serostatus and COMT genotype on working memory and prefrontal function in women. For the behavioral study, 54 HIV-infected and 33 HIV-uninfected women completed the 0-, 1-, and 2-back conditions of the verbal Nback, a working memory test. For the imaging study, 36 women (23 HIV-infected, 13 HIV-uninfected) underwent functional magnetic resonance imaging (fMRI) assessments while completing the N-back task. HIV-infected women demonstrated significantly worse N-back performance compared with HIV-uninfected women (p < 0.05). A significant serostatus by genotype interaction (p<0.01) revealed that,
Introduction
HIV targets the central nervous system within days after infection, which ultimately leads to neurological, behavioral, and cognitive complications (Brew et al. 1988; Grant et al. 1989; McArthur 1994) . Even after the introduction of combined antiretroviral therapy (cART), mild neurocognitive deficits persist in approximately 45 % of individuals with HIV/ AIDS particularly in the domains of executive function, learning, and memory (Heaton et al. 2011) . Compared with HIVinfected men, HIV-infected women may be at increased risk for cognitive decline due to poverty, low education, substance abuse, and barriers to health care services prevalent in predominantly minority, urban-dwelling populations (Basso and Bornstein 2000; Bornstein et al. 1993; Maki and Martin 2009) . Genetic factors that put HIV-infected individuals at risk for neurocognitive deficits are not well known, especially in women. This study examines whether a genetic polymorphism in the catechol-O-methyltransferase gene (COMT) is associated with deficits in neurocognitive functions dependent on integrity of prefrontal circuitry such as executive function in women with HIV.
The COMT enzyme is responsible for the metabolic degradation of catecholamines, primarily dopamine (DA) (Lachman et al. 1996) , with a high degree of activity in the prefrontal cortex (PFC) (Garris et al. 1993) . The Val158Met (rs4680) single-nucleotide polymorphism (SNP) of the COMT gene influences the activity and thermal stability of the COMT enzyme (Lachman et al. 1996) , whereby Met/Met homozygotes have approximately one quarter of the enzyme activity compared with the Val/Val genotype (Bilder et al. 2004) . This reduction in COMT activity results in slower DA breakdown and increased synaptic DA availability, particularly in the PFC (Chen et al. 2004; Lotta et al. 1995) . Therefore, the Met/Met genotype shows the greatest level of DA signaling in the PFC and the Val/Val genotype shows the least.
The COMT Val158Met polymorphism influences PFCmediated cognitive domains that are dependent on DA, particularly executive functions such as working memory (Tunbridge et al. 2006; Farrell et al. 2012) . The relationship between PFC DA levels and executive function is typically characterized by an inverted U-shaped curve where levels at the peak of the curve are optimal for executive function. Conversely, DA levels to the left or right of the peak lead to poorer performance on these tasks (Cai and Arnsten 1997; Granon et al. 2000; Zahrt et al. 1997; Cools and D'Esposito 2011; Egan et al. 2001 ). For example, in both healthy adults and individuals with schizophrenia, Val/Val participants demonstrate poorer performance on executive function tasks, including working memory (Egan et al. 2001; Goldberg et al. 2003; Minzenberg et al. 2006) , suggesting that for those groups, the lower levels of prefrontal DA associated with the Val/Val genotype results in suboptimal levels that fall to the left of the peak. In neuroimaging studies, the Val allele was associated with increased prefrontal activation during working memory tasks in individuals with schizophrenia (Egan et al. 2001; Ho et al. 2005 ) and healthy adults (Bertolino et al. 2006; Heinz and Smolka 2006; Jacobs and D'Esposito 2011; MeyerLindenberg et al. 2006) . The increased PFC activation in low DA, Val/Val participants is interpreted as representing decreased brain processing efficiency (Heinz and Smolka 2006; Jacobs and D'Esposito 2011; Meyer-Lindenberg et al. 2006) .
To our knowledge, no study to date has examined the interactive associations between COMT genotype and HIV serostatus on working memory and its neural correlates. The HIV virus is indirectly neurotoxic to DA neurons by way of released, neurotoxic proteins (Bennett et al. 1995; Itoh et al. 2000; Reyes et al. 1991) . HIV-infected cells infiltrate the DArich basal ganglia (Navia et al. 1986 ) and secrete toxic viral proteins including Tat and gp120 that result in DA dysregulation and excitotoxicity leading to cell death (Koutsilieri et al. 2001) . In vivo and in vitro studies have shown that dopaminergic neurons are functionally and structurally susceptible to the effects of Tat and gp120 including oxidative stress, functional alterations in cell receptors, and apoptosis (Agrawal et al. 2010; Aksenova et al. 2006; Ferris et al. 2009 ). For example, in vitro studies have found that DA neurons treated with the HIV Tat protein show a significant decrease in binding of the DA transporter (Aksenova et al. 2006 ) and inhibited expression of tyrosine hydroxylase (TH), the ratelimiting enzyme in the DA synthesis pathway (Zuali et al. 2000) .
The DA dysfunction in HIV contributes to working memory deficits (Woods et al. 2009; Kumar et al. 2011) . HIV is associated with deficits on multiple working memory tasks (Farinpour et al. 2000; Martin et al. 2001; Sun et al. 2010) , including the N-back (Hinkin et al. 2002) . In fMRI studies using the N-back test, symptomatic and asymptomatic HIVinfected men showed significantly greater brain activation in bilateral PFC compared with HIV-uninfected men. Similar to Val/Val carriers, the greater activation was interpreted as decreased processing efficiency (Chang et al. 2001; Ernst et al. 2002) . Here, we examine the effect of COMT genotype on Nback performance and on patterns of brain activation during the N-back, in a sample of HIV-infected and HIV-uninfected women. We hypothesized that HIV serostatus and the Val/Val genotype would be associated with poorer working memory performance and greater PFC activation during the N-back. Based on the assumption that HIV-infected individuals with the Val/Val genotype have suboptimal DA levels that fall to the left of the peak, we also hypothesized that the Val/Val genotype would compound the negative effect of HIV on working memory such that HIV-infected Val/Val carriers would show the worst N-back accuracy and the greatest PFC activation overall.
Methods and materials

Participants
Participants were recruited from the Chicago Women's Interagency HIV Study (WIHS) Consortium.
Behavioral study Inclusionary criteria included consent to genetic testing and English as a first language. We enrolled 140 women (97 HIV-infected and 44 HIV-uninfected), 34 of whom were excluded because of: self-reported use of a stimulant drug in the past 6 months (n=18), antipsychotic medication use (n=4), serious head injury (n=4), stroke or cerebrovascular disease (n=3), diabetes (n=2), self-reported dementia (n=1), AIDS-defining illness (i.e., history of a CD4 count <200 cells/mm 3 ; n=1), and fewer than 8 years of formal education (n=1) because of the complexity of the memory task. Nine women (8 % HIV-infected and 9 % HIV-uninfected) were further excluded due to below chance (less than 25 % accuracy) or outlier (>3 SDs from mean) behavioral performance on the N-back. Ninety-seven participants were included in the final sample.
Imaging study Inclusionary and exclusionary criteria were the same as the behavioral study with the addition of age ≥60 years, metal in the body, claustrophobia, weight ≥250 lbs (due to scanner dimensions), and a positive pregnancy or toxicology test (DrugCheck 5 panel cup by Express Diagnostics International). Toxicology tests were used only in the fMRI study to exclude individuals who used illicit substances within 24 h to 10 days of testing. The detection time is based on the varying half-life of illicit drugs, including cocaine, amphetamine/metamphetamine, opiate, phencyclamine, and THC in urine. Bilinguals were excluded because the brain systems subserving tasks that rely on verbal stimuli differ between native English speakers and bilinguals (Proverbio et al. 2002) . Forty-six women were enrolled in the imaging study. Ten women were excluded from analysis for the following reasons: positive toxicology screen for illicit drug use (n = 2), movement in excess of two voxels (6.25 mm; n=6), and below chance or outlier performance on the N-back (n=2). The final sample included 36 (23 HIVinfected) participants, 22 of whom previously participated in the behavioral study.
Measures N-back The N-back (Postle et al. 2000 ) is a widely-used, parametrically-designed working memory task, which incrementally varies working memory load. There are three conditions, each consisting of 40 trials: the 0-, 1-, and 2-back. In each condition, a letter is presented every 1.8 s for 200 ms on a computer screen. In the 0-back, the participant is instructed to press the "yes" button every time a previously designated target letter is presented. The 0-back is used as the control condition because it does not involve a memory load and is a measure of attention and stimulus response time. In the 1-back, the participant is instructed to press "yes" when the letter presented matches the previously presented letter. In the 2-back, the participant is instructed to press "yes" when the letter presented matches the letter presented two trials earlier. The primary outcome was percent accuracy per condition, and the secondary outcome was average reaction time per condition.
Procedure
Behavioral study The N-back was incorporated into Chicago WIHS Consortium Core visits from May to November 2008. During the biannual WIHS visit, participants were asked about sociodemographic and health-related variables including medication use, drug and alcohol use, and depressive symptoms as measured by the Center for Epidemiological Studies Depression Scale (CES-D) (Radloff 1997) . CD4 absolute count (T helper cell count) and plasma HIV RNA viral load were measured for HIV-infected women. The Wide Range Achievement Reading Test-Revised (WRAT-R) (Jastak et al. 1984) , a measure of educational attainment, was also obtained.
Imaging study Participants completed a 2.5-h study visit at the UIC Center for Magnetic Resonance (MR) Research, and provided a urine sample for toxicology (DrugCheck 5 panel cup by Express Diagnostics) and pregnancy testing (hCG Urine Pregnancy Test Strip). Before scanning, participants received detailed instructions on the N-back and practiced a computerized N-back task. The in-scanner N-back was similar to the behavioral study except that the trials per condition were truncated from 40 to 35 to allow for a manageable scanning time.
Blood oxygen level-dependent (BOLD) imaging was performed on a General Electric 3.0 Tesla scanner. Thirty-seven images were acquired in an oblique, axial plane. The fMRI Nback test was administered using a block design with the following acquisition parameters: TR=2000 ms, TE=25 ms, flip angle 90°, NEX=1, acquisition matrix=64x64, FOV= 20 cm 2 , slices=37, slice thickness=3 mm, skip=1 mm, bandwith=62.5 kHz, volumes=270, acquisition time=8:56. Structural MRI was performed with a three-dimensional inversion recovery-prepared spoiled gradient-recalled echo acquisition.
Genotyping
Genotyping for Val158Met (rs4680) was done as part of the genome wide association study in WIHS at Illumina Assay Services in San Diego, CA using validated commercially available assays from Applied Biosystems (www. appliedbiosystems.com).
Data analysis
Behavioral study Based on previous COMT and working memory studies (Minzenberg et al. 2006; Bertolino et al. 2006; Jacobs and D'Esposito 2011) , we assessed relationships between genotype and neurocognitive outcomes assuming a dominant genetic model (i.e., Val/Val vs. Met allele carriers). We examined the main and interactive associations of HIV serostatus and COMT genotype on demographic and clinical characteristics with analyses of variance (ANOVAs) for continuous variables and Chi-squares (χ 2 ) for categorical variables. Any variable that significantly differed between genotype or serostatus groups and significantly related to the Nback performance was included in the analysis as a covariate. To examine the independent and interactive associations of serostatus, COMT genotype, and N-back condition, a mixedfactor ANOVA was conducted with N-back condition (0-, 1-, and 2-back) as the within-subject factor and HIV serostatus (HIV+ vs. HIV−) and COMT genotype (Val/Val vs. Met allele carriers) as the between-subject factors. To address potential bias associated with population stratification, we also conducted analyses within an African-American sample. All pvalues were two-sided (p<0.05). Analyses were performed using SPSS (version 18.0 for Windows; SPSS, Chicago, IL).
fMRI study Preprocessing and analysis of the neuroimaging data was completed using statistical parametric mapping (SPM8, Welcome Department of Imaging Neuroscience, London, UK). MRI data were converted to ANALYZE format. Preprocessing steps included motion correction (realignment), co-registration between functional images and the EPI template, spatial normalization, and spatial smoothing smoothed with an 8-mm Gaussian kernel. A first-level analysis step was conducted to determine regionally activated brain volumes in individual participants using a general linear model and convolved with the hemodynamic (BOLD) response function. To examine activation associated with working memory, brain activation during the control condition (0-back) was subtracted from that during each of the experimental conditions (1-and 2-back).
A second-level, full-factorial model examined the effects of COMT genotype (Val/Val; Met allele carriers), serostatus (HIV+, HIV−) and condition (1-and 2-back) as predictors. A threshold of p<0.01 (uncorrected, minimum cluster size ≥15) was used for two-and three-way interactions. A threshold of p<0.05 (uncorrected, minimum cluster size k=15) was used to further probe significant interactions. We conducted a region of interest analysis based on brain regions reported as significantly active during the N-back in previous fMRI studies including the bilateral PFC and posterior parietal cortex, anterior cingulate, caudate, and putamen (Egan et al. 2001; Bertolino et al. 2006; Heinz and Smolka 2006; Jacobs and D'Esposito 2011; Meyer-Lindenberg et al. 2006) . Anatomical localization of significant activations was determined using the xjView toolbox (http://www.alivelearn.net/xjview). Unlike the behavioral study, we did not repeat analyses in an African-American subsample because that would remove only 2 of 33 fMRI participants.
The DNA sequence corresponding to the SNP analyzed was derived from the National Center for Biotechnology Information (NCBI) SNP Database (dbSNP) using the accession number, rs4680. As found in the WIHS more generally (Sundermann et al. 2013 ), more HIV-infected women carried the Met allele (67 %) than HIV-uninfected women (37 %), p=0.13. Therefore, the cognitively disadvantageous genotype was more prevalent among the HIV-uninfected (cognitively advantaged) group, an effect that might mask the negative effect of the Val/Val genotype and the positive effect of seronegativity. We, therefore, evaluated the interactive effect of genotype and serostatus by stratifying by genotype and examining the effect of serostatus within each genotype separately. Genotype distributions were in Hardy-Weinberg equilibrium for the full sample, χ 2 =0.6, p>0.05 and for African Americans, the predominant race group, χ 2 =0.08, p>0.05. Accuracy, but not reaction time, changed with increasing difficulty in the N-back, p<0.05 (Fig. 1) . The covariate, past drug use, had a significant, negative effect on N-back performance in the overall sample (p<0.01); however, the interactive effect of past drug use and genotype was not significant (p=0.76). As hypothesized, HIV-infected women had lower accuracy across N-back conditions (M=69.3, SE=1.5) compared with HIV-uninfected women (M = 75.3, SE = 2.2; p<0.05). Contrary to our hypothesis, there was no main effect of genotype. There was, however, a significant serostatus by genotype interaction (p<0.01) such that, among Val/Val carriers, but not among Met carriers, accuracy was significantly lower in HIV-infected women (M=67.2, SE=2.5) vs. SE=2.8; p<0.001) . No other interactions were significant (p>0.05). Results did not change when analysis was restricted to African Americans (HIV-infected=55 and HIV-uninfected=24). 
Results
Behavioral study
ns not significant (p<0.05), WRAT Wide-Range Achievement Test, CES-D depressive symptoms measured by Center for Epidemiologic Studies Depression Scale with >16 cut-off, Recently within 6 months of the most recent WIHS visit, CD4 level T helper cell count per cubic millimeter of blood, CD4 nadir lowest recorded CD4 level to date, cART combined antiretroviral therapy, ART antiretroviral therapy a Relative to >7 drinks/week or more than four drinks in one sitting
Imaging study The imaging sample included 36 women (23 HIV+, 13 HIV−) with an average age of 43.0 (SD=8.5), with 95 % African American and 79 % high school graduates. Among HIV-infected women, 6 % had a current CD4+ lymphocyte count <200 cells/μl, 60 % had an undetectable plasma HIV RNA level, and 85 % received cART treatment. Serostatus and genotype groups did not differ on any demographic or clinical characteristic. The imaging sample was similar to the behavioral sample except that those in the imaging study were less likely to show depression (15 vs. 37 %) and more likely to be African American (94 vs. 81 %). Among HIV-infected women, those in the imaging study were more likely to graduate high school (80 vs. 67 %) and had lower rates of hepatitis C (21 vs. 36 %). Genotype distributions were in Hardy-Weinberg equilibrium for the entire sample (χ 2 =0.07, p>0.05), and for African Americans, the predominant race group (χ 2 =0.29, p>0.05). As in the behavioral study and in studies of HIV-infected women more generally (Sundermann et al. 2013) , the distribution of COMT genotype differed by HIV serostatus (χ 2 = 7.9, p=0.005). Again, the proportion of carriers of the typically beneficial allele (Met) was significantly higher in HIVinfected women (65 %) compared with HIV-uninfected women (38 %), and the proportion of carriers of the Val allele was significantly higher in HIV-uninfected (62 %) women compared with the HIV-infected women (35 %). This confounder reduces the likelihood of detecting the overall effects of HIV and genotype. Therefore, we again stratified by genotype and examined the effect of serostatus to probe the interaction between serostatus and HIV.
With increasing difficulty across N-back conditions (0-, 1-, and 2-back), percent accuracy decreased (p values <0.001) and reaction time increased (p values <0.001). In contrast to the behavioral study, serostatus and COMT genotype had no independent or interactive associations on N-back percent accuracy or reaction time (p values >0.05).
There was a significant main effect of N-back condition on brain activation across serostatus groups; as working memory load increased from the 1-to 2-back conditions, BOLD signal increased in the right posterior parietal lobe (BA7), right dorsolateral PFC (DLPFC; BA9), left superior frontal gyrus (BA8), bilateral middle frontal gyrus (BA46, BA8, BA11) and left inferior frontal gyrus (BA11). Table 2 provides the Talairach coordinates and statistical values for each brain region showing significantly greater activation in the 2-vs. the 1-back.
As shown in Table 3 , serostatus interacted with genotype to alter BOLD signal in the left anterior cingulate (BA32), right anterior cingulate (BA32), right DLPFC (BA10), and right middle frontal gyrus (BA11). Among Val/Val carriers, HIVinfected women showed greater activation in the left anterior cingulate (BA24), right anterior cingulate (BA32), right DLPFC (BA10), and right medial frontal gyrus (BA11). Conversely, among Met allele carriers, HIV-uninfected controls showed significantly greater activation in the right medial frontal gyrus (BA11) and the left anterior cingulate (BA32) compared with the HIV-infected individuals (Fig. 2) . Table 3 also shows results of the significant serostatus× genotype×condition interaction characterized by increased activation in the right anterior cingulate (BA32, k=174, z= 4.12) and left medial frontal gyrus (BA9, k=15, z=3.35). These significant clusters were driven by HIV-infected Val/ Val carriers in the 2-back condition.
Discussion
This two-part investigation examined performance and functional neuroimaging outcomes on the N-back as a function of COMT genotype and serostatus in women. As predicted based on findings from predominantly male, HIV+ cohorts (Farinpour et al. 2000; Martin et al. 2001; Sun et al. 2010; Hinkin et al. 2002; Stout et al. 1995) , HIV-infected women showed impaired N-back performance compared with HIVuninfected controls. Contrary to our hypotheses, the Val/Val genotype did not relate to poorer N-back performance when all study participants (cases and controls) were examined together. HIV-infected women in this subsample were more likely to have a beneficial Met allele than HIV-uninfected women. The same Met allele frequency difference was previously found in comparisons between HIV-infected and HIVuninfected women in the general WIHS population (Sundermann et al. 2013) , demonstrating that this Met allele imbalance between serostatus groups generalizes to a population of multi-racial, low-income women and is not simply a sampling bias within this subsample. The higher proportion of Met allele carriers among HIV-infected women might be due to the positive association between Met allele and propensity for risk-taking (Bousman et al. 2010a; Amstadter et al. 2012; van den Bos et al. 2008) . After stratifying by genotype, we found poorer working memory performance in HIV-infected Val/Val carriers vs. HIV-uninfected Val/Val carriers but no effect of serostatus among Met carriers. These findings occurred across N-back conditions, suggesting that, together, HIV serostatus and Val/Val genotype negatively affect attentional processes, short-term memory, and more complex updating and temporal indexing components of working memory. Among Val/Val carriers, activation was greater in the anterior cingulate and medial frontal gyrus among HIVinfected compared with HIV-uninfected women. The statistical results suggest that the COMT genotype has a moderating effect on the relationship between HIV serostatus and prefrontal function such that the negative effects of HIVon executive function might become evident only in the context of lower baseline dopaminergic function (Val/Val genotype). An inverted U-shaped curve characterizes the relationship between executive function performance and PFC DA levels (Cai and Arnsten 1997; Granon et al. 2000; Zahrt et al. 1997; Egan et al. 2001) . It is plausible that HIV-infected women with the Val/Val genotype may fall to the left of this curve to a point representing lowered PFC DA levels and compromised performance. Alternatively, the effect of HIV on working memory might not be robust enough to be detected clinically in asymptomatic individuals who have the advantageous Met allele and the associated increase in PFC DA levels. Two previous studies investigated the effect of COMT genotype on executive function in HIV but involved predominantly male cohorts and did not include HIV-uninfected controls (Bousman et al. 2010b; Levine et al. 2012) . Consistent with our findings, a study of 192 HIV-infected, non-methamphetamine users found an association between the Met/Met genotype and better executive function (Bousman et al. 2010b ). Conversely, a study of 184 HIVinfected individuals (87 % male) in more advanced stages of HIV (mean CD4=219) found no effect of COMT genotype on the Letter-Number Sequencing test (LNS) and the Paced Auditory Serial Addition Test (Levine et al. 2012) . The discrepancy between that study and the others might be due to the inclusion of individuals with more advanced disease where the effect of disease might mask any COMT effect (Stout et al. 1995; York et al. 2001) ; the use of the LNS which might be less sensitive than the N-back to COMT (Bousman et al. 2010b ); or to low female representation (13 %).
Our neuroimaging findings revealed a HIV serostatus by genotype interaction such that Val/Val carriers showed increased brain activation during the N-back in DLPFC, anterior cingulate cortex, and medial PFC. These brain areas are reliably activated during working memory tasks in studies of HIV or COMT (Egan et al. 2001; Minzenberg et al. 2006; Heinz and Smolka 2006; Jacobs and D'Esposito 2011; MeyerLindenberg et al. 2006) . DLPFC is most reliably activated in neuroimaging studies of COMT and working memory, due to its role in multiple working memory processes including the monitoring and manipulation of information held in working memory (Owen 1997; Petrides 1994) , response selection (Rowe et al. 2000) , and strategy use (Bor et al. 2003 (Bor et al. , 2004 . The anterior cingulate is interconnected with the PFC (Posner and DiGirolamo 1998) and richly innervated by midbrain DA projections (Seamans and Yang 2004) . Activation in anterior cingulate is observed in tasks involving attention, error detection and decision making, suggesting that this region helps to coordinate multiple cognitive processes associated with a challenging task (Posner and DiGirolamo 1998; Chein and Schneider 2005; Kondo et al. 2004; Petersen et al. 1989) . Evidence suggests that the bilateral medial PFC regulates uncertainty (Elliott et al. 1999; Fukui et al. 2005; Volz et al. 2003 Volz et al. , 2004 and is activated in response to guessing demands two-choice guessing task (Elliott et al. 1999) . The N-back might invoke a substantial degree of uncertainty, particularly the 2-back, because participants are instructed to respond to each trial even if they are unsure of the answer (mean 2-back %accuracy=63 %; chance performance=25 % accuracy). The brain regions with increased PFC activation in relation to working memory load were similar to the brain regions that showed greater activation in HIV-infected vs. HIV-uninfected Val/Val carriers (right middle frontal gyrus, right DLPFC, right posterior parietal cortex). The increased activation in HIV-infected Val/Val carriers might represent greater effort and compensatory recruitment of a larger network of brain areas in order to maintain behavioral competency. Supporting this interpretation, activation was greatest among HIVinfected Val/Val carriers in the 2-vs. 1-back condition. Although some brain regions showed greater activation in HIV-uninfected vs. HIV-infected Met allele carriers, they did not overlap with brain areas related to working memory load.
Our study has limitations. First, the sample size in the behavioral study is similar to other studies investigating COMT and cognition, but our imaging sample included only 11 HIV-uninfected Met allele carriers. Second, toxicology screens were used in the neuroimaging, but not the behavioral study. Although reported rates of current substance use are low among this group of HIV-infected women, we cannot exclude the possibility that covert drug use confounded the behavioral results. Past, illicit drug use was prevalent in our sample, differed by serostatus in the behavioral study and had a significant, negative effect on N-back performance. Although we cannot exclude the possibility of past drug use impacting results, we minimized this impact by adjusting for past drug use and demonstrating no significant interactive effects of past drug use and genotype indicating that the effect of drug use is consistent across genotypes. Third, our sample included women only. While not a limitation per se, results cannot be generalized to men, particularly in light of the role of COMT in metabolizing catecholestrogens and estrogen's agonistic effect on DA (Becker 2000; Thompson and Moss 1994; Xiao and Becker 1994) . Fourth, menopause status differed across serostatus and genotype groups but did not relate to N-back performance and did not influence the findings when used as a covariate.
As a major strength, this is the first investigation of the interactive effects of COMT genotype and HIV serostatus on working memory and PFC function and the largest neuroimaging study of HIV-infected women to date. Together, HIV serostatus and the Val/Val COMT genotype, which has been associated with suboptimal DA levels, were associated with working memory deficits and inefficient PFC function. COMT genotype might represent a biomarker to identify HIV-infected individuals at risk for working memory deficits.
